BR112015001798A2 - método e sistema para gerenciar diabetes usando múltiplos indicadores de risco para uma pessoa com diabetes - Google Patents

método e sistema para gerenciar diabetes usando múltiplos indicadores de risco para uma pessoa com diabetes

Info

Publication number
BR112015001798A2
BR112015001798A2 BR112015001798A BR112015001798A BR112015001798A2 BR 112015001798 A2 BR112015001798 A2 BR 112015001798A2 BR 112015001798 A BR112015001798 A BR 112015001798A BR 112015001798 A BR112015001798 A BR 112015001798A BR 112015001798 A2 BR112015001798 A2 BR 112015001798A2
Authority
BR
Brazil
Prior art keywords
diabetes
person
managing
multiple risk
risk indicators
Prior art date
Application number
BR112015001798A
Other languages
English (en)
Inventor
Schaible Thomas
Original Assignee
Lifescan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifescan Inc filed Critical Lifescan Inc
Publication of BR112015001798A2 publication Critical patent/BR112015001798A2/pt

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/48785Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply
    • G01N33/48792Data management, e.g. communication with processing unit
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Abstract

resumo patente de invenção: "método e sistema para gerenciar diabetes usando múltiplos indicadores de risco para uma pessoa com diabetes". a presente invenção refere-se a métodos e sistemas para anunciar ao paciente os componentes envolvidos em cada um dos riscos da faixa de risco diário, com base nas medições de glicose, para auxiliar o paciente a identificar se é hipoglicemia ou hiperglicemia que está direcionando a faixa de risco diário dos valores de glicose medidos.
BR112015001798A 2012-07-27 2013-07-25 método e sistema para gerenciar diabetes usando múltiplos indicadores de risco para uma pessoa com diabetes BR112015001798A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/560,627 US20140030748A1 (en) 2012-07-27 2012-07-27 Method and system to manage diabetes using multiple risk indicators for a person with diabetes
PCT/US2013/051947 WO2014018709A2 (en) 2012-07-27 2013-07-25 Method and system to manage diabetes using multiple risk indicators for a person with diabetes

Publications (1)

Publication Number Publication Date
BR112015001798A2 true BR112015001798A2 (pt) 2017-07-04

Family

ID=49995257

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015001798A BR112015001798A2 (pt) 2012-07-27 2013-07-25 método e sistema para gerenciar diabetes usando múltiplos indicadores de risco para uma pessoa com diabetes

Country Status (10)

Country Link
US (1) US20140030748A1 (pt)
EP (1) EP2880429A4 (pt)
JP (1) JP2015528725A (pt)
KR (1) KR20150038189A (pt)
AU (1) AU2013295755A1 (pt)
BR (1) BR112015001798A2 (pt)
CA (1) CA2880019A1 (pt)
HK (1) HK1210634A1 (pt)
TW (1) TW201415404A (pt)
WO (1) WO2014018709A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10383580B2 (en) 2012-12-31 2019-08-20 Abbott Diabetes Care Inc. Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
US9351670B2 (en) 2012-12-31 2016-05-31 Abbott Diabetes Care Inc. Glycemic risk determination based on variability of glucose levels
AU2014233094B2 (en) 2013-03-15 2020-07-02 Abbott Diabetes Care Inc. System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk
WO2017132663A1 (en) * 2016-01-29 2017-08-03 Patek Stephen D Method, system, and computer readable medium for virtualization of a continuous glucose monitoring trace
JP6976957B2 (ja) * 2016-02-05 2021-12-08 アニマス エルエルシー 薬物送達システムのための可視化及び解析ツール

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695949A (en) * 1995-04-07 1997-12-09 Lxn Corp. Combined assay for current glucose level and intermediate or long-term glycemic control
WO2001072208A2 (en) * 2000-03-29 2001-10-04 University Of Virginia Patent Foundation Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data
RU2477078C2 (ru) * 2006-01-05 2013-03-10 Юниверсити Оф Вирджиния Пэйтент Фаундейшн Способ, система и компьютерный программный продукт для оценки изменчивости содержания глюкозы в крови при диабете по данным самоконтроля
US7824333B2 (en) * 2006-03-31 2010-11-02 Lifescan, Inc. Diabetes management methods and systems
US9317657B2 (en) * 2008-11-26 2016-04-19 University Of Virginia Patent Foundation Method, system, and computer program product for tracking of blood glucose variability in diabetes
US9117015B2 (en) * 2008-12-23 2015-08-25 Roche Diagnostics Operations, Inc. Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
RU2012112589A (ru) * 2009-09-02 2013-10-10 Юниверсити Оф Вирджиния Пэйтент Фаундейшн Отслеживание вероятности приближающейся гипогликемии при диабете на основе данных самостоятельного контроля глюкозы в крови

Also Published As

Publication number Publication date
EP2880429A4 (en) 2017-07-26
CA2880019A1 (en) 2014-01-30
US20140030748A1 (en) 2014-01-30
TW201415404A (zh) 2014-04-16
AU2013295755A1 (en) 2015-03-12
WO2014018709A3 (en) 2015-06-04
JP2015528725A (ja) 2015-10-01
HK1210634A1 (en) 2016-04-29
WO2014018709A2 (en) 2014-01-30
EP2880429A2 (en) 2015-06-10
KR20150038189A (ko) 2015-04-08

Similar Documents

Publication Publication Date Title
BR112015001038A2 (pt) método e sistema para indicar hiperglicemia ou hipoglicemia para pessoas com diabetes
BR112015001798A2 (pt) método e sistema para gerenciar diabetes usando múltiplos indicadores de risco para uma pessoa com diabetes
BR112015015932A2 (pt) método e dispositivo para exibir informações de notificação
BR112015017767A2 (pt) sistema para detectar estágios do sono de um indivíduo, método para detectar estágios do sono de um indivíduo, e, sistema configurado para detectar estágios do sono de um indivíduo
BR112012020270A2 (pt) sistema e método para administrar medicamentos com base em valores de urina.
MX2016004899A (es) Metodos para evaluar el desarrollo de bebes y niños via rastreo ocular.
BR112015023650A2 (pt) dispositivos, sistemas, e métodos para distribuição percutânea de componentes
BR112014027594A2 (pt) dispositivo para apoiar uma mudança de comportamento de uma pessoa, método para apoiar uma mudança de comportamento de uma pessoa utilizando um dispositivo e programa de computador
BR112012024813A8 (pt) método e sistema para mostrar dados de sensor de analito
BR112015016094A8 (pt) ajuda de entrada para um veículo ferroviário ou um veículo automotor com apoio em três pontos
BR112015019570A2 (pt) verificação de compatibilidade de aplicativo em um ambiente de computação distribuído
BR112015005519A2 (pt) método e sistema para indicar os impactos glicêmicos dos comandos da bomba de infusão de insulina
BR112014021178A2 (pt) determinação de orientações anatômicas
HK1146118A1 (en) Blood glucose level measuring system
BR112015022473A2 (pt) método e sistema para prever a resposta a tratamentos contra a dor
BR112014000113A2 (pt) sistema e método para prever a viabilidade de um tecido corporal em um paciente e dispositivo de medição para medir a pressão de perfusão local em um tecido corporal de um paciente
BR112015018209A2 (pt) avaliação e recomendação em relação à nutrição e resistência
BR112013031431A2 (pt) método para o diagnóstico da doença de gaucher
BR112015030099A2 (pt) marcador para desordens de esfingomielinase ácida e usos do mesmo
WO2014072823A3 (en) Device for blood glucose level determination
Barnard et al. Is iatrogenic sleep disturbance worth the effort in Type 1 diabetes?
BR112015031139A2 (pt) método e sistema para analisar um grau de uma disfunção autônoma de um sistema nervoso autônomo
BR112014019274A2 (pt) métodos relacionados ao tratamento de doenças e distúrbios inflamatórios
Nair Herpes zoster: mistaken for radiculopathy and back pain.
Scheitler et al. Superimposed Hypercoagulable and Hypocoagulable States: Elevated Von Willebrand Factor (vWF) Levels Secondary to Polycystic Ovary Syndrome Masking Von Willebrand Disease

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]